Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Revista Colombiana de Cardiología
Print version ISSN 0120-5633
Abstract
MACHADO-DUQUE, Manuel E.; GAVIRIA-MENDOZA, Andrés and MACHADO-ALBA, and Jorge E.. Prevalence of lipid-lowering drug use. Rev. Colomb. Cardiol. [online]. 2021, vol.28, n.1, pp.14-17. Epub Mar 19, 2021. ISSN 0120-5633. https://doi.org/10.24875/rccar.m21000003.
Introduction:
Among the main causes of death in Colombia, Latin America, and the general population are pathologies of cardiovascular origin, which have an important relationship with dyslipidemias.
Objective:
The objective of the study was to establish the prevalence of the use of lipid-lowering drugs in a Colombian population during 2016.
Material and methods:
A cross-sectional study was conducted using a population database of the Colombian Health System between January and June 2016. Site: outpatients of Colombia. Participants. Researchers considered all patients who had received this class of drug to establish the prevalence of the use of lipid-lowering drugs. Main measurements. Prevalence of use of lipid-lowering drugs.
Results:
From a population of 4,328,688 patients, a total of 282,002 were prescribed a lipid-lowering drug; the mean age was 64.2 ± 13.3 years and women comprised 50.4% of the users. The estimated prevalence of lipid-lowering drug use was 6.5%. Statins (86.3%) were the most commonly used lipid-lowering drugs (atorvastatin: 81.0%, lovastatina: 14.4%) followed by fibrates (13.1%) and ezetimibe (0.6%).
Conclusions:
A low proportion of people are being treated with lipid-lowering drugs, according to the estimated prevalence of dyslipidemia.
Keywords : Statins; Hypercholesterolemia; Epidemiology; Pharmacology.